A Retrospective Real-World Comparison of Topical Delgocitinib and Localized Cream Psoralen–Ultraviolet A in Chronic Hand Eczema

Key Points

• To compare the clinical efficacy of delgocitinib and PUVA in managing chronic hand eczema.
• Conducted a retrospective analysis of patient records
• Compared outcomes between delgocitinib and PUVA treatments
• Measured disease control and quality of life improvements
• Both treatments showed comparable short-term efficacy in chronic hand eczema
• Delgocitinib demonstrated a numerically greater reduction in DLQI scores
• Proactive maintenance with delgocitinib may help sustain control of the disease